Aprea Therapeutics Inc (APRE)
$4.75
Insights on Aprea Therapeutics Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 72.6% return, outperforming this stock by 41.0%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 235.1% return, outperforming this stock by 330.1%
Performance
- $4.54$4.82$4.75
4.34%
Downside
Day's Volatility :5.73%
Upside
1.45%
- $2.78$8.85$4.75
41.47%
Downside
52 Weeks Volatility :68.59%
Upside
46.33%
Returns
| Period | Aprea Therapeutics Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -43.45% | 0.0% |
6 Months | 28.38% | 0.0% |
1 Year | 33.8% | 0.0% |
3 Years | -94.98% | -22.6% |
Highlights
Market Capitalization | 25.8M |
Book Value | $4.54 |
Earnings Per Share (EPS) | -3.24 |
Wall Street Target Price | 15.67 |
Profit Margin | 0.0% |
Operating Margin TTM | -26109.62% |
Return On Assets TTM | -36.63% |
Return On Equity TTM | -63.19% |
Revenue TTM | 583.2K |
Revenue Per Share TTM | 0.16 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -15.5M |
Diluted Eps TTM | -3.24 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -2.57 |
EPS Estimate Next Year | -0.78 |
EPS Estimate Current Quarter | -0.78 |
EPS Estimate Next Quarter | -0.81 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 229.89%
Technicals Summary
Sell
Neutral
Buy
Aprea Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Aprea Therapeutics Inc | -9.7% | 28.38% | 33.8% | -94.98% | -98.84% |
 Moderna, Inc. | 21.03% | 85.08% | 14.68% | -28.27% | 659.22% |
 Regeneron Pharmaceuticals, Inc. | 3.22% | 20.18% | 31.88% | 93.3% | 227.58% |
 Novo Nordisk A/s | 8.85% | 34.38% | 71.83% | 235.07% | 463.44% |
 Vertex Pharmaceuticals Incorporated | 16.81% | 34.1% | 40.6% | 123.97% | 174.53% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Aprea Therapeutics Inc | 0.48 | NA | NA | -2.57 | -0.63 | -0.37 | NA | 4.54 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.14 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 28.89 | 28.89 | 1.46 | 44.13 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 46.97 | 46.97 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 29.59 | 29.59 | 0.53 | 17.08 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Aprea Therapeutics Inc | Buy | $25.8M | -98.84% | 0.48 | 0.0% |
Moderna, Inc. | Buy | $54.6B | 659.22% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.0B | 227.58% | 28.89 | 29.45% |
Novo Nordisk A/s | Buy | $602.6B | 463.44% | 46.97 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $117.5B | 174.53% | 29.59 | 39.46% |
Institutional Holdings
AIGH Capital Management, LLC
6.43%Sio Capital Management, LLC
5.09%Sphera Funds Management Ltd.
4.97%Nantahala Capital Management, LLC
3.79%Dafna Capital Management LLC
2.53%Vanguard Group Inc
2.14%
Company Information
annan naturvetenskaplig och teknisk forskning och utveckling
Organization | Aprea Therapeutics Inc |
Employees | 7 |
CEO | Dr. Oren Gilad Ph.D. |
Industry | Commercial Services |
Discover More
A Spac I Acquisition Corp
$4.75
-0.42%
Keyarch Acquisition Corp
$4.75
-0.42%
Connexa Sports Technologies Inc
$4.75
-0.42%
Us Value Etf
$4.75
-0.42%
First Wave Biopharma Inc
$4.75
-0.42%
Global X Msci Next Emerging
$4.75
-0.42%
Fat Projects Acquisition Corp
$4.75
-0.42%
Goal Acquisitions Corp
$4.75
-0.42%
Capital Link Global Fintech
$4.75
-0.42%